arrow
T

Timothy C. Burn

incyte research institute
H指数:51
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TYRA-300, an oral, FGFR3-selective inhibitor: Preliminary pharmacokinetic and pharmacodynamic analysis from SURF301, the multicenter open-label phase 1/2 study of TYRA-300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 alterations
2024-10-010
PRE
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
Nature
IF48.5
2022-08-100
OAAI
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
2022-07-2335
OA
Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor
2021-07-1645
PREAI
Parsaclisib Is a Next-Generation Phosphoinositide 3-Kinase δ Inhibitor with Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy
2020-07-0135
OAAI
The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination Strategies
2019-01-0335
OAAI
The LSD1 specific inhibitor INCB059872 enhances the activity of mechanistically distinct immunotherapeutic agents in the syngeneic 4T1 mouse mammary tumor model
2018-01-010
PRE
INCB040093 Is a Novel PI3Kδ Inhibitor for the Treatment of B Cell Lymphoid Malignancies
2018-01-0121
OAAI
Preclinical characterization of the potent and selective BET inhibitor INCB057643 in models of hematologic malignancies
2017-07-0110
PRE
Selective inhibition of FGFR4 by INCB062079 is efficacious in models of FGF19-and FGFR4-dependent cancers
2017-07-013
PRE